By Reuters - Fri Jul 3, 7:45 AM PDT NEW YORK (Reuters Health) - PSA blood tests are often used to screen men for prostate cancer, but there is still no good evidence that they cut death rates from the disease, a new review finds. Prostate cancer screening still unproven: report (Reuters) 50% of users found this article helpful. Based on two recent major clinical trials, the practice of routinely screening men with the PSA test has "at best" a small effect on deaths from prostate cancer, according to the review, published in CA: A Cancer Journal for Clinicians. The studies, which came out earlier this year in The New England Journal of Medicine, appear to bolster the positions of the American Cancer Society (ACS) and other major medical groups, which do not recommend routine PSA screening for symptom-free men at average risk...
[read full story]
powered by 